Kewaunee Scientific Corporation · NASDAQ:KEQU
Kewaunee Scientific — Shareholder Meeting (August 2022)
22 slides from Kewaunee Scientific's shareholder meeting presentation, Aug 24, 2022
Slide 1: Kewaunee Scientific Corporation – encouraging new discovery…Worldwide
Kewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery…Worldwide Exhibit 99.1
Slide 2: Forward-Looking Statements
Certain statements in this document constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements other than statements of historical fact included in this document, including statements regarding the Company’s f
Slide 3: Agenda
Kewaunee Scientific Corporation | NASDAQ: KEQU Agenda Kewaunee Scientific Overview Fiscal Year 2022 Review Strategic Direction and Outlook Q&A
Slide 4: Overview
Kewaunee Scientific Corporation | NASDAQ: KEQU Kewaunee Scientific Corporation Overview
Slide 5: Kewaunee Scientific Overview: Key Facts
Kewaunee Scientific Corporation | NASDAQ: KEQU Kewaunee is a leading global designer, manufacturer, and installer of specialized equipment and technical furniture products for laboratories across an array of industries, including life sciences, education, government, healthcare, and general research
Slide 6: Industries served continue to receive investment prioritization
Kewaunee Scientific Corporation | NASDAQ: KEQU The industries served by Kewaunee continue to receive prioritization for investment dollars as companies, governments, and institutions look to encourage discovery that is dependent on investment in research and development. Kewaunee Scientific Overview
Slide 7: R&D spending as percent of GDP
Kewaunee Scientific Corporation | NASDAQ: KEQU Kewaunee Scientific Overview “According to The World Bank, in the US, 3.5% of GDP was spent on research and development in 2020 (the latest year of data), which is an increase of one full percentage point relative to 1996. Since 1996, US GDP has risen a
Slide 8: Active in multiple end-use sectors
Kewaunee Scientific Corporation | NASDAQ: KEQU Kewaunee is active in multiple sectors, providing geographical and industry diversification. The diversity of end-use segments for the Company’s products supports a narrative of growth and end-market expansion for Kewaunee. Kewaunee Scientific Overview
Slide 9: Domestic segment overview
Kewaunee Scientific Corporation | NASDAQ: KEQU Kewanee is a North American leader in manufactured laboratory, healthcare, and technical furniture. Kewaunee’s Domestic Segment primarily relies on its dealer and distribution network to sell its products to end users. Kewaunee Scientific Overview Desig
Slide 10: International segment overview
Kewaunee Scientific Corporation | NASDAQ: KEQU Kewaunee’s International segment participates more broadly across the laboratory construction value chain, from pre-construction through providing facility maintenance services for customers with market leading positions in India and the Middle East. Ke
Slide 11: FY 2022 Review
Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2022 Review
Slide 12: FY 2022 Review – Consolidated Results
Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2022 Review – Consolidated Results *EBITDA is a non-GAAP measure; please see the Appendix for a reconciliation to net earnings.
Slide 13: FY 2022 Review – Domestic Segment
Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2022 Review – Domestic Segment FY 2022 Impacts: Inflation impacts that could not be passed along to customers due to the fixed nature of contracts approximated $4.6M. Volumes returned, however, labor shortages prevented ramping workforce to pre-Covid
Slide 14: FY 2022 Review – International Segment
Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2022 Review – International Segment FY 2022 Impacts: Strength in the Indian market driven by strong investments across the life sciences, petroleum and technology markets. Raw material inflation impacts approximate $0.6M The Middle East and ASEAN mar
Slide 15: FY 2022 Review – Corporate Segment
Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2022 Review – Corporate Segment Corporate Segment: CEO and CFO compensation Corporate finance and global treasury Stock based incentive compensation Public company costs Pension administration Expenses related to the amortization of the underfunded p
Slide 16: Strategic Direction and Outlook
Kewaunee Scientific Corporation | NASDAQ: KEQU Strategic Direction and Outlook
Slide 17: Vision: global supplier of choice in laboratory furniture and infrastructure
“To be the global supplier of choice with customers in the laboratory furniture and infrastructure markets.” Kewaunee Scientific Corporation | NASDAQ: KEQU Strategic Direction and Outlook
Slide 18: Our Guiding Principles
Kewaunee Scientific Corporation | NASDAQ: KEQU We will be easy to do business with. We will get closer to our customer(s). We will lead and not follow (we are innovators). Our Guiding Principles We will do everything with excellence. Strategic Direction and Outlook
Slide 19: Thank You and Questions
Kewaunee Scientific Corporation | NASDAQ: KEQU Thank You and Questions
Slide 20: encouraging new discovery…Worldwide
Kewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery…Worldwide
Slide 21: Appendix
Kewaunee Scientific Corporation | NASDAQ: KEQU Appendix
Slide 22: Non-GAAP Reconciliations
Kewaunee Scientific Corporation | NASDAQ: KEQU Non-GAAP Reconciliations Kewaunee Scientific Corporation Kewaunee Scientific Corporation Annual Shareholder Meeting | August 24, 2022 Appendix: Non-GAAP Measures (Dollars in Thousands) The following unaudited tables reconcile Net Earnings to EBITDA, by
Kewaunee Scientific — Shareholder Meeting (August 2022) on 6ix